Pages that link to "Q36399427"

The following pages link to Increased cancer risks in myotonic dystrophy. (Q36399427):

Displaying 30 items.

• Myotonic disorders: A review article (Q26747746) (← links)
• Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma Developed in a Patient with Progressive Muscular Dystrophy: A Case Report and Review of the Literature (Q33786885) (← links)
• Diagnostic odyssey of patients with myotonic dystrophy (Q34172180) (← links)
• Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis (Q35043905) (← links)
• Correlates of tumor development in patients with myotonic dystrophy (Q36312821) (← links)
• Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts (Q36603853) (← links)
• CELFish ways to modulate mRNA decay (Q36807677) (← links)
• Cancer-related genes in the transcription signature of facioscapulohumeral dystrophy myoblasts and myotubes (Q37595289) (← links)
• Recent advances in myotonic dystrophy type 2. (Q38179289) (← links)
• Myotonic Dystrophy Type 1 Management and Therapeutics (Q39003493) (← links)
• Post-transcriptional regulation of cytokine and growth factor signaling in cancer (Q39036700) (← links)
• Benign and malignant tumors in the UK myotonic dystrophy patient registry (Q40141012) (← links)
• Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy (Q40285957) (← links)
• Brain tumors in patients with myotonic dystrophy: a population-based study. (Q40385181) (← links)
• A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy (Q40807674) (← links)
• Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors. (Q40995588) (← links)
• Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink. (Q47635841) (← links)
• Imaging of the thymus in myotonic dystrophy type 1. (Q48234370) (← links)
• Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage (Q48243281) (← links)
• Core Clinical Phenotypes in Myotonic Dystrophies. (Q55189250) (← links)
• Systematic thyroid screening in myotonic dystrophy: link between thyroid volume and insulin resistance (Q64242883) (← links)
• Myotonic dystrophy (Q87411199) (← links)
• Uveal Melanoma Associated With Myotonic Dystrophy: A Report of 6 Cases (Q88214879) (← links)
• A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma (Q88489320) (← links)
• Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis (Q90365229) (← links)
• Survival patterns and cancer determinants in families with myotonic dystrophy type 1 (Q90557252) (← links)
• Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity (Q90575137) (← links)
• Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1 (Q92071105) (← links)
• Benign tumors in myotonic dystrophy type I target disease-related cancer sites (Q92554679) (← links)
• Myotonic Dystrophy-2: Unusual Phenotype Due to a Small CCTG-expansion (Q93089641) (← links)